Advancing Pharmaceutical Supply Chain: Rules & Regulations, Strategies for Overcoming Challenges

The pharmaceutical supply chain plays a critical role in ensuring the safe and efficient distribution of medications. However, challenges such as demand variability, logistical complexities, regulatory compliance, and counterfeit drugs threaten its stability. This study explores regulatory frameworks, distribution channels, emerging challenges, and the transformative role of technology in enhancing supply chain resilience. Regulations like DSCSA, EU FMD, GDP, and WHO guidelines safeguard product integrity through strict documentation, serialization, and tracking. Despite these measures, disruptions from supply shortages, pandemics, geopolitical tensions, and cold chain vulnerabilities persist. To address these issues, pharmaceutical firms adopt multisourcing strategies, flexible logistics, and digital monitoring. Distribution networks range from direct manufacturer-to-pharmacy models to complex multi-tier systems, including e-commerce and direct-to-patient delivery, which improve access but introduce regulatory challenges.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-01
DOI
https://doi.org/10.5281/zenodo.15117522
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advancing Pharmaceutical Supply Chain: Rules & Regulations, Strategies for Overcoming Challenges

Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Quality and Counterfeiting
article

Advancing Pharmaceutical Supply Chain: Rules & Regulations, Strategies for Overcoming Challenges

article en

Abstract

The pharmaceutical supply chain plays a critical role in ensuring the safe and efficient distribution of medications. However, challenges such as demand variability, logistical complexities, regulatory compliance, and counterfeit drugs threaten its stability. This study explores regulatory frameworks, distribution channels, emerging challenges, and the transformative role of technology in enhancing supply chain resilience. Regulations like DSCSA, EU FMD, GDP, and WHO guidelines safeguard product integrity through strict documentation, serialization, and tracking. Despite these measures, disruptions from supply shortages, pandemics, geopolitical tensions, and cold chain vulnerabilities persist. To address these issues, pharmaceutical firms adopt multisourcing strategies, flexible logistics, and digital monitoring. Distribution networks range from direct manufacturer-to-pharmacy models to complex multi-tier systems, including e-commerce and direct-to-patient delivery, which improve access but introduce regulatory challenges.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 39%
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.